Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast Cancer
Clinical trial NCT01479036 · UNKNOWN
Trial details
- NCT number
- NCT01479036
- Sponsor
- Xijing Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2014-12-01
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.